INIBIDOR DE PROTEÍNA DE TRANSFERÊNCIA DE ÉSTER DE COLESTERÍLIO (CETP) E COMPOSIÇÕES FARMACÊUTICAS QUE COMREENDEM O REFERIDO INIBIDOR PARA USP NO TRATAMENTO OU PREVENÇÃO DA DOENÇA CARDIOVASCULARS
(hereinafter referred to as Compound A) for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, in particular hyperlipidemia or mixed dyslipidemia. A further aspect of the present invention relates to a pharmaceutical composition for use in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, wherein the composition comprises a therapeutically effective amount of said Compound A CETP inhibitor.